Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 4 Lung Neoplasms 3 Lymphatic Metastasis 2 Venous Thrombosis 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stage IV or Unresectable Gastric Cancer 1 Rectal Neoplasms 1 Pilonidal Sinus 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Pain 1 Neoplastic Cells, Circulating 1 Neoplasms 1 Malignant Neoplasm of Transverse Colon 1 Locally Advanced Gastric Cancer 1 Kidney Neoplasms 1 Endometrial Neoplasms 1 Colorectal Liver Metastasis 1 Choledochal Cyst 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Gemcitabine 683 130-nm albumin-bound paclitaxel 198 Fluorouracil 188 Oxaliplatin 175 Albumin-Bound Paclitaxel 154 Capecitabine 137 Leucovorin 131 Irinotecan 112 Radiotherapy 96 Taxes 85 pembrolizumab 81 Cisplatin 72 Erlotinib Hydrochloride 70 Radiosurgery 69 Nivolumab 56 Drug Therapy 56 Bevacizumab 54 Magnetic Resonance Spectroscopy 50 Cyclophosphamide 49 folfirinox 45 Specimen Handling 42 Docetaxel 42 Cetuximab 40 irinotecan sucrosofate 38 Biopsy 38 S 1 (combination) 36 Pancreaticoduodenectomy 35 Blood Specimen Collection 34 Surgical Procedures, Operative 31 Paclitaxel 30

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Neoplasms × Conversion to Open Surgery × Clear all

NCT02081131 2015-09-15

PLOT

GEM Hospital & Research Center

Phase NA Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡